Morgan Stanley analyst Patrick Wood maintains TransMedics Gr (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $104 to $145.
Morgan Stanley Maintains Equal-Weight on TransMedics Gr, Raises Price Target to $145
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.